Connor, Clark & Lunn Investment Management Ltd.
Position in RDY — Dr Reddys Laboratories Ltd
CIK 1596800
VANCOUVER, A1
Position in RDY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$5,304,217
+$49,719 QoQ
Shares Held
382,976
+2.3% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $123,963,967 across 16 Drug Manufacturers - Specialty & Generic names. RDY ranks #8 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
649,629 | $31,279,636 | |
| 2 | ZTS |
Zoetis Inc.
|
187,329 | $22,144,161 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
153,755 | $20,255,683 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
471,891 | $14,213,356 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
868,325 | $12,069,717 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,835,424 | $6,442,338 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
648,377 | $5,381,529 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
This page
|
382,976 | $5,304,217 |
All Filings in RDY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,304,217 | 382,976 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,254,498 | 374,252 | Shares | Sole | 2026-02-10 | |
| 2025-03-31 | $419,626 | 31,814 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,826,039 | 305,639 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $12,352,965 | 155,481 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,709,310 | 48,685 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,386,696 | 59,805 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,460,773 | 64,110 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,192,054 | 77,644 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,468,333 | 102,493 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,014,931 | 70,524 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $8,558,622 | 165,384 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,665,281 | 108,240 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,852,950 | 105,668 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,838,626 | 68,879 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,873,699 | 74,510 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,412,453 | 67,738 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,463,864 | 47,121 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,818,721 | 45,915 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $935,396 | 13,121 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $867,879 | 16,372 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,211,916 | 30,050 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||